Global /India /Healthcare /Medical Distribution /524723

Bijoy Hans Ltd.

524723 (BIJHANS)

• BSE: 524723 • Delayed

55.23INR 0%

0.5790 USD

As of 6 June 2026, Bijoy Hans Ltd. has a market cap of $27.7M USD, ranking #34801 globally and #2359 in India. It ranks #3138 in the Healthcare sector, and #137 in the Medical Distribution industry.

Global Rank

34801

Country Rank

2359

Sector Rank

3138

Industry Rank

137

Key Stats

Market Cap

$27.7MUSD

2.65B INR

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Medical Distribution

CEO

Kaushal Shah open_in_new

Founded

1985

Website

bijoyhans.net open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	0%	5%	10%	16%	10%	140%	150%	162%

News

Markets

Exchange	Ticker	Price	Quotes
Bombay Stock Exchange (BSE / BOM) MIC: XBOM PRIMARY	524723 (BIJHANS) Bijoy Hans Ltd ISIN: INE491D01017 TV: TradingView: BSE: BIJHANS SA: Stock Analysis: BOM: 524723 YF: Yahoo Finance: 524723.BO GF: Google Finance: BOM: 524723 BA: Barron's: 524723 MS: Morningstar: XBOM: 524723	55.23 INR	TV: TradingView: BSE: BIJHANS SA: Stock Analysis: BOM: 524723 YF: Yahoo Finance: 524723.BO GF: Google Finance: BOM: 524723 BA: Barron's: 524723 MS: Morningstar: XBOM: 524723

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Bijoy Hans Ltd.

Bijoy Hans Limited engages in the trading of bulk drugs, pharmaceuticals, and cosmetics in India. It offers various pharmaceutical formulations, including tablets, capsules, syrups, suspension, and powders focusing on various segments, such as antibiotics, cough/cold/allergy, H-1receptor antagonist (antiulcerant), nutraceuticals, and NSAIDS. The company is also involved in the investment activities. Bijoy Hans Limited was incorporated in 1985 and is based in Guwahati, India.

Similar Companies

Industry: Medical Distribution (India)

Name	Market Cap (USD) diff.	PE	Country
Entero Healthcare Solutions Ltd. NSE: ENTERO	$541.39M 51.84B INR 2K%	46.1	India
Aptus Pharma Ltd. BSE: APPL	$33.19M 3.18B INR 20%	-	India
Everest Organics Ltd. BSE: 524790	$27.37M 2.62B INR -1.2%	44.6	India
VijayPD Ceutical Ltd. NSE: VIJAYPD	$21.22M 2.03B INR -23%	27.1	India
Rama Vision Ltd. BSE: 523289	$19.35M 1.85B INR -30%	36.3	India
S Speciality Medicines Ltd. BSE: SPML	$19.11M 1.83B INR -31%	-	India

Industry: Medical Distribution (Global)

Name	Market Cap (USD) diff.	PE	Country
McKesson Corp. NYSE: MCK	$100.76B 364K%	24.0	United States
Cencora, Inc. NYSE: COR	$60.58B 219K%	37.4	United States
Cardinal Health, Inc. NYSE: CAH	$47.73B 172K%	29.6	United States
Henry Schein, Inc. NASDAQ: HSIC	$8.47B 30K%	22.6	United States
Sinopharm Group Co. Ltd. SHEK: 1099	$7.48B 58.61B HKD 27K%	7.2	China
Galenica AG SIX: GALE	$5.32B 4.2B CHF 19K%	23.0	Switzerland

chevron_leftBack